Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 200 clinical trials
Pancreatic Adenocarcinoma Signature Stratification for Treatment (PASS-01)

This is a randomized multicentre phase II trial with a large translational component. The trial will evaluate the two standard chemotherapy regimens: modified folfirinox (mFFX) and gemcitabine/nab-paclitaxel (GA), in patients with untreated metastatic pancreatic ductal adenocarcinoma. Integrated into this phase II trial are a number of laboratory components including molecular …

  • 0 views
  • 02 May, 2022
  • 6 locations
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

least 70% of patients diagnosed with advanced pancreatic adenocarcinoma, treated at the "Hermanos Ameijeiras" Surgical Clinical Hospital. Phase II clinical trial, open, multicenter, nonrandomized.

ocoxin
neutrophil count
advanced pancreatic adenocarcinoma
nutritional supplement
leukocyte count
  • 4 views
  • 24 Feb, 2022
  • 1 location
Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma represents more than 90% of pancreatic neoplasms. Around 14000 new cases of pancreatic adenocarcinoma are being diagnosed each year in France and about 8.6% in Grand

diabetes
carcinogenesis
ct scan
a 10
cancer
  • 0 views
  • 05 Oct, 2021
  • 1 location
Chemo4METPANC Combination Chemokine Inhibitor Immunotherapy and Chemotherapy in Pancreatic Adenocarcinoma

prolong life in patients, and if it's safe. The treatment consists of standard chemotherapy (gemcitabine and nab-paclitaxel) which is FDA approved and is standard treatment for patients with pancreatic

neutrophil count
thromboplastin
blood cell count
irinotecan
pancreatic adenocarcinoma
  • 1 views
  • 29 Nov, 2021
Liposomal Irinotecan S-1 and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

In present study, the investigators evaluate the safety and efficacy of OIS-derived NASOX regimen (nal-IRI, S-1, oxaliplatin) in advanced pancreatic cancer. NASOX regimen contains nal-IRI, which has recently been proven effective in pancreatic cancer.

oxaliplatin
pancreatic adenocarcinoma
adenocarcinoma
irinotecan
biliary obstruction
  • 0 views
  • 26 Jul, 2021
  • 2 locations
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma

with adenocarcinoma of the pancreas. Subjects will be staged prior to protocol entry by contrast-enhanced helical abdominal CT scan done using a pancreas mass protocol or EUS. Eligible subjects with

  • 0 views
  • 13 Aug, 2021
  • 1 location
Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer

This study is for the verification of biomarkers for pancreatic cancer treatment using small RNA liquid biopsy, combined with EUS-FNA tissues.

  • 0 views
  • 26 Jan, 2021
  • 1 location
PRECISE: Pancreatic Cancer and Exercise

The purpose of this study is to establish the feasibility of delivering a prescribed, individualised supervised aerobic and resistance exercise programme during adjuvant therapy, to improve survival and reduce symptom burden in pancreatic cancer

  • 0 views
  • 27 Dec, 2021
  • 1 location
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.

  • 0 views
  • 12 Sep, 2021
  • 1 location
tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr (ORIENTATE)

The study is designed to assess the therapeutic efficacy of decitabine repurposing against advanced, refractory, ductal adenocarcinoma (PDAC) with molecular transcriptional signatures indicating dependency on the KRAS oncogene

  • 0 views
  • 11 May, 2022
  • 1 location